Instructions for Authors

The Editor welcomes submissions to JBI which adhere to the Instructions for Authors. Manuscripts that do not meet all of the requirements below will not be considered for publication and may be returned to the authors for completion. Please submit your manuscript on the Journal's Manuscript Central page.

For support and more information please contact the JBI editorial office at [email protected].

• About the Journal
• Submissions
• Manuscript Types
• Manuscript Preparation
• Processes
• Post-Publication Corrections
• Open Access
• Ethical Policies
• Data Policy

About the Journal

Aims and Scope

JBI, the official journal of the Society of Breast Imaging, is a peer-reviewed publication that aims to provide high quality, evidence-based content for the global breast imaging medical community. This journal seeks to advance the field of breast imaging, with a particular focus on improving patient care and outcomes. JBI; will publish original research, as well as reviews of important scientific, educational and clinical topics.

Among the topics covered are screening for breast cancer, diagnosis of disease, image-guided breast procedures, and imaging management of patients with breast cancer. The journal will review emerging and controversial topics by experts to summarize evidence-based research and practice while updating readers on practice management topics. JBI will maintain a strong clinical focus with broad appeal with the goal of advancing the field of breast imaging.

Submissions

The JBI considers all manuscripts on the condition that:

• the manuscript is your own original work and does not duplicate any other previously published work, including your own work.
• the manuscript has been submitted only to JBI. It should not be under consideration or peer review or accepted for publication or published elsewhere.
• the manuscript contains nothing that is abusive, defamatory, libelous, obscene, fraudulent, or illegal.

Submission to JBI is free. All manuscripts are submitted and reviewed via the journal's web-based manuscript submission system, ScholarOne. To submit to the journal, go to mc.manuscriptcentral.com/jbri. New authors should create an account prior to submitting a manuscript for consideration. Questions about submitting to the journal should be sent to the editorial office at [email protected].

More information about using ScholarOne.

Manuscript format, structure, and style

Article type guide

Manuscript Types

Overview

Science of Screening

These are brief summary reviews on focused breast cancer screening topics. These manuscripts may be invited by the editor, but unsolicited submissions are equally welcome.

• Word count: no more than 3500 words (Introduction to Discussion)
• Abstract: Unstructured and no more than 250 words
• Reference Limit: 80
• Figure Limit (images, charts, or graphs): 3
• Table Limit: 3
• Required Key Messages: 2-3 bulleted sentences summarizing the important findings of your manuscript
• Please see a representative example of this manuscript type.

Original Research

These articles communicate new knowledge gained through original research or meta-analysis. Studies should have a stated hypothesis with appropriate statistical analyses. For human studies, please include institutional review board (IRB) and Health Insurance Portability and Accountability Act (HIPAA) compliance (U.S. studies) information as appropriate at the beginning of the methods section. In addition, please include if informed consent was obtained or waived by the IRB. For a retrospective study an example statement may be “This study was approved by our institutional review board who granted a waiver of consent. The study was compliant with the Health Insurance Portability and Accountability Act (HIPAA).” If the submitted work represents a prospective clinical trial, please include registry information such as from ClinicalTrials. For animal studies, include appropriate ethics approval.

• Word count: no more than 4500 words (Introduction to Discussion)
• Abstract: Structured and no more than 250 words
• Reference Limit: 35 (limit may be extended for meta-analyses)
• Figure Limit (images, charts, or graphs): 6
• Table Limit: 4
• Required Key Messages: 2-3 bulleted sentences summarizing the important findings of your manuscript.

Scientific Review Articles

These are comprehensive focused reviews of the scientific literature written by experts in the field. These should not present new research work or meta-analysis. These manuscripts may be invited by the editor, but unsolicited submissions are equally welcome.  All will undergo peer-review.

• Word count: no more than 4500 words (Introduction to Conclusion)
• Abstract: Unstructured and no more than 250 words
• Reference Limit: 100
• Figure Limit (images, charts, or graphs): 8
• Table Limit: 4
• Required Key Messages: 2-3 bulleted sentences summarizing the important findings of your manuscript.
• Please see a representative example of this manuscript type.

Educational Review Articles

These are comprehensive focused summary articles with the purpose of organizing information to educate readers. These will typically be image rich with text to explain teaching points, but do not require the same degree of depth as a Scientific Review article. These manuscripts may be invited by the editor, but unsolicited submissions are equally welcome. These will all undergo peer review. CME will be offered with each of these articles once published.

• Word count: no more than 3500 words (Introduction to Conclusion)
• Abstract: Unstructured and no more than 250 words
• Reference Limit: 50
• Figure Limit (images, charts, or graphs): 12
• Table Limit: 4
• Required Key Messages: 2-3 bulleted sentences summarizing the important findings of your manuscript.
• Please see a representative example of this manuscript type.

Clinical Practice

These are focused summary articles on topics related to the operation and clinical practice of breast imaging. They should not present new data or meta-analysis and do not have the depth of scientific reviews. These manuscripts may be invited by the editor, but unsolicited submissions are equally welcome. These will all undergo peer review.

• Word count: no more than 3000 words (Introduction to Conclusion)
• Abstract: Unstructured and no more than 250 words
• Reference Limit: 35
• Figure Limit (images, charts, or graphs): 6
• Table Limit: 4
• Required Key Messages: 2-3 bulleted sentences summarizing the important findings of your manuscript.
• Please see a representative example of this manuscript type.

Radiologic–Pathologic Correlation

The goal of these articles is to facilitate assessment of radiologic-pathologic concordance (and recognition of discordance) after image-guided needle biopsy.  It is expected that one or two radiologists will work closely with a pathologist (no more than 4 authors) to select a minimum of 3 and maximum of 5 cases with paired imaging-pathology images that are high-quality illustrative examples of the entity presented and its varied manifestations. These will undergo peer review.  Preference will be given to less common entities where there may be diagnostic or management dilemmas.  It is recommended that authors contact the Associate Editor in advance to assure the topic has not been previously covered nor is in process.

Authors can review the literature on the topic, creating a table of important imaging findings across the literature for uncommon entities.  Alternatively, if recent prior good-quality reviews exist, those can be cited. Authors can also include new case series from their own institution in addition to reviewing the prior published literature.

Each figure legend should start with the patient age, clinical history/presentation, and diagnosis.  A composite figure of multiple parts that includes imaging and pathology for that patient should be created.  Arrows should indicate key imaging and pathology findings. The clinical BI-RADS assessment should be included in the legend whenever possible. The images should be shown chronologically, according to the clinical events. Information in the figure legends should not be repeated in the text.

• Abstract: Unstructured, not more than 200 words
• Articles should include an Introduction (200 words), Imaging Findings (500 words), Pathologic Findings (300 words), Management/Discussion (400 words).
• Overall length:  Up to 1500 words
• References: Not more than 25
• Please see a representative example of this manuscript type.

Training and Professional Development

These are focused summary articles on topics related to training and professional development, as it pertains to breast imaging. They may be original science or review articles. These articles may relate to aspects of teaching/learning, transitioning to practice, developing leadership skills, etc., and should support information with appropriate references whenever possible. Examples of articles in this section include how to teach US-guided biopsy, developing an academic career, using coaching for professional development, and a survey of fellowship directors regarding the virtual interview process.  Articles focused on personal experience are best suited for the SBI Newsletter. These manuscripts may be invited by the editor, but unsolicited submissions are equally welcome. All manuscripts will undergo peer review.

• Word count: no more than 3000 words (Introduction to Conclusion)
• Abstract: Unstructured and no more than 250 words (unless the work represents original research)
• Reference Limit: 35
• Figure Limit (images, charts, or graphs): 6
• Table Limit: 4
• Required Key Messages: 2-3 bulleted sentences summarizing the important findings of your manuscript.
• Please see a representative example of this manuscript type.

Image Spotlight

These are images that represent either an innovative imaging or interventional technique, or an exceptional example of an uncommon entity in breast imaging. This is not a forum for case reports. These do not undergo peer review and are accepted at the discretion of the editor.

• Brief Title of 8 words or less
• Authors: no more than 2 authors
• Figure Limit: 4
• Brief description: no more than 500 words
• No references
• Please see a representative example of this manuscript type.

Unknown Challenge

These are unknown cases with high-quality images and the following components: history, imaging findings, differential diagnosis, and discussion.  These cases should be challenging, but the reader should be able to make the most likely diagnosis based on the information provided.  These are not meant to be case reports.  No more than two authors are allowed.  These cases do not undergo peer review and are accepted at the discretion of the editor.

• History.  There should be a few brief sentences of pertinent history.
• Images.  Four to six images should be provided and the image legends should include a description of the findings, and the images should have relevant arrows or other markers.
• Imaging Findings.  Brief text that summarizes the findings, building the case for the correct diagnosis.
• Differential Diagnosis.  Briefly review the differential diagnosis and why the history and image finding point to the correct diagnosis.
• Diagnosis. A single statement.
• Discussion. Brief review of the diagnosis, including the imaging features, prevalence, and outcome. No more than 250 words.
• Reference limit: 8.
• Please see a representative example of this manuscript type.

Editorials

These are invited by the editor and reflect the opinions of the author. These will review the relevance and importance of an Original Research article relevant to other works. These will typically be written by a single author. Additional authors will be considered at the editor’s discretion. Editorials do not undergo peer review and are accepted at the discretion of the editor.

• Word count: no more than 1200 words
• Abstract: None
• Reference Limit: 20
• Figure Limit (images, charts, or graphs): typically none
• Table Limit: typically none

Statement/Guidelines

Scientific statements or medical guidelines submissions will be considered as received from authoritative medical groups or societies. These must be relevant to breast imaging and include a comprehensive review of the literature supporting the position offered. These must be vetted and approved by the submitting society or medical group prior to submission.

Manuscript Preparation

General formatting guidance

Please avoid jargon, such as “breast imagers,” using “breast imaging radiologists” or “breast radiologists” instead. Likewise, a more formal style is preferred to informal. As such, in general, avoid personal pronouns. For example, instead of “Next we excluded women under age 40 years” try “Women under age 40 years were excluded.”

BI-RADS can be used in the abstract. In the manuscript, please expand at first use as Breast Imaging Reporting and Data System (BI-RADS) and cite per the ACR recommendation. If different editions were used, then cite each separately. If citing only a portion of the lexicon (e.g. mammography, US, MRI or Quality), instructions for correct citation are also available at this website.

MLO and CC. At first use in the text, please spell out as mediolateral oblique (MLO) and craniocaudal (CC). In the figure legends or tables, just use MLO and CC. If MLO or CC are not included in the text of the paper, then MLO and CC should be spelled out in the first figure used.

For hormone receptor information, the following formats can be used:

Please specify equipment used if appropriate by stating the type of equipment followed by the manufacturer and their headquarters. For example, “US examinations were performed using L17-5 MHz transducers (Philips iU22, Amsterdam, Netherlands).”

Figures

Images should be of the highest resolution available for that modality. Generally 300 dpi is the minimum acceptable resolution for publication. Screen captures are rarely of sufficient resolution for publication. Please crop parts of the image that do not contribute to the message (e.g. black background on mammography, focal zones on US, excess field-of-view on MRI).

Upon acceptance for publication or acceptance with minor/major revision, please add embedded figure labels that are appropriate in size and location for publication. Text within figures is typically not edited during production. Ensure that a consistent, embedded typeface is used. Common typefaces such as Arial, Helvetica, Courier or Symbol are recommended to ensure clear reproduction and the retention of any special characters. Size of labels should be consistent throughout the figure. Similarly, please ensure that the size and thickness of arrows or other markers is sufficient for publication. Dashed and solid arrows are preferred over colored arrows when multiple arrows are needed. All findings should be marked by an arrow (or other object) and noted in the figure legend (arrow), even when the finding seems obvious

Example:

Figure accessibility and alt text

Incorporating alt text (alternative text) when submitting your paper helps to foster inclusivity and accessibility. Good alt text ensures that individuals with visual impairments or those using screen readers can comprehend the content and context of your figures. The aim of alt text is to provide concise and informative descriptions of your figure so that all readers have access to the same level of information and understanding, and that all can engage with and benefit from the visual elements integral to scholarly content. Including alt text demonstrates a commitment to accessibility and enhances the overall impact and reach of your work.  

Alt text is applicable to all images, figures, illustrations, and photographs. 

Alt text is only accessible via e-reader and so it won’t appear as part of the typeset article. 

Detailed guidance on how to draft and submit alt text. 

Graphical abstracts

Authors are encouraged to submit a graphical abstract as part of the article, in addition to the text abstract. The graphical abstract should clearly summarize the focus and findings of the article, and will be published as part of the article online and in PDF. The graphical abstract should be submitted for peer review as a separate file, selecting the appropriate file-type designation in the journal’s online submission system. The file should be clearly named, e.g. graphical_abstract.tiff. See this page for guidance on appropriate file format and resolution for graphics. Please ensure graphical abstracts are in landscape format.

Processes

Peer review

JBI adheres to a policy of double-anonymized peer reviewing, in which the identity of the author is, as far as possible, kept from reviewers, whilst reviewers’ names are kept confidential from authors. The Editor has oversight over reviewer and author names. Authors are therefore encouraged to avoid explicit disclosure of their identity in the text of their manuscript; for example, by referencing a prior publication as originating with the authors.

All submissions to the journal are initially reviewed by one of the journal editors. At this stage, manuscripts may be rejected without peer review if it is felt that they are not relevant to the journal or are not of high enough priority. This fast rejection process means that authors are given a quick decision and do not need to wait for the review process to be completed.

Manuscripts that are not initially rejected are sent out for peer review, usually to two independent reviewers. Based on the feedback from these reviewers and the editors’ judgment, a decision is given on the manuscript. Authors will normally be notified of acceptance, acceptance contingent upon minor or major revision, rejection- resubmission will be considered, or rejection. It is anticipated that minor revisions will be returned within 30 days, while major revisions will be returned within 60 days. A second set of reviews may be requested.

For full details about the peer review process, see Fair editing and peer review.

OUP author FAQs.

Production process

For JBI, manuscripts arrive at OUP and go through the production process until final versions are ready to publish. These are then published on our Advance Access page. They will remain on the page up until the issue that they are assigned to is published.

Authors will receive a link to the PDF proof of their manuscript on our online system by email, and it is essential that a current email address is supplied with all manuscripts. Proofing instructions will accompany the PDF file but the proof should be checked immediately upon receipt and uploaded in accordance with covering instructions. Only essential corrections should be made at the proof stage.

Post-Publication Corrections

Authors should notify the JBI Editorial Office as soon as possible if errors or omissions are found in their published article, particularly errors that could affect the interpretation of data or reliability of the information presented. Changes to a published article (version of record) should be submitted to JBI under the category Post-Publication Correction, in the form of a correction notice providing the details of the error and the requested changes. Requests for post-publication corrections will be considered by the Editor-in-Chief and will be made in accordance with guidance from the Committee on Publication Ethics (COPE). It is the responsibility of the corresponding author to ensure consensus has been reached with all co-authors before requesting a correction. Depending on the nature of the correction, a correction notice (and in rare cases an Expression of Concern or Retraction) will accompany all post-publication corrections. To ensure the integrity of the scholarly record, the correction notice will be permanently linked with the original article. Corrections requested to articles within 12 months of publication will be implemented in the originally published article to reflect changes detailed in the notice. If a correction is requested for an article after 12 months have passed, the original article will not be updated when a notice is published to preserve the academic version of record. 

JBI supports trans and non-binary authors who wish to update their name following article publication. Such a change will NOT be accompanied by a correction notice. For more information, please contact the JBI Editorial Office or OUP at [email protected] for more information.

Open Access

Some funders require open access publication as a condition of funding. If you are unsure whether you are required to publish open access, please clarify requirements with your funder or institution.

If you select an open access license, you must pay the open access charge or request to use an institutional agreement to pay the open access charge through our licensing and payment portal, SciPris.

Should you wish to publish your article open access, you should select your choice of open access licence in our online system after your article has been accepted for publication. You will need to pay an open access charge to publish under an open access licence.

Details of the open access licences and open access charges. 

OUP has a growing number of Read and Publish agreements with institutions and consortia which provide funding for open access publishing. This means authors from participating institutions can publish open access, and the institution may pay the charge. Find out if your institution is participating.

To be eligible for one of OUP’s Read and Publish agreements, the corresponding author must provide their qualifying institution as their primary affiliation when they submit their manuscript. After submission, changing the corresponding author in order to access Read and Publish funding is not permissible.

Members of the Society of Breast Imaging are eligible for a 20% discount on the open access charge. Authors may be asked to prove eligibility for the member discount.

Ethical Policies

Authors should observe high standards with respect to publication best practice, including those set out by the Commission on Publication Ethics (COPE), and the International Committee of Medical Journal Editors (ICMJE). All research published in the Journal must have been conducted in a fair and ethical manner. Falsification or fabrication of data, plagiarism, including duplicate publication of the authors’ own work without proper citation, and misappropriation of work are all unacceptable practices. Any cases of ethical or publication malpractice are treated very seriously and will be managed in accordance with the Committee on Publication Ethics (COPE) guidelines. Wherever appropriate, the Journal requires that all research be done according to international and local guidelines.

Further information about OUP’s ethical policies.

Authorship

Authorship is limited to those who have made a significant contribution to the design and execution of the work described. Any contributors whose participation does not meet the criteria for authorship should be acknowledged but not listed as an author.

The Journal does not allow ghost authorship, where an unnamed author prepares the article with no credit, or guest/gift authorship, where an author who made little or no contribution is listed as an author. The Journal follows Committee on Publication Ethics (COPE) guidance on investigating and resolving these cases. For more information, please see the OUP Publication Ethics page.

Natural language processing tools driven by artificial intelligence (AI) do not qualify as authors, and the Journal will screen for them in author lists. The use of AI (for example, to help generate content or images, write code, process data, or for translation) should be disclosed both in cover letters to editors and in the Methods or Acknowledgements section of manuscripts. Authors must also disclose, in their cover letter and in the Methods or Acknowledgements section of the manuscript, if AI tools were used to assist with the preparation of the manuscript including medical writing and editing for spelling, punctuation, grammar and language. Authors must specify how the AI tool was used and the name of the AI tool or language model that was used. Please see the COPE position statement on Authorship and AI for more details.

After manuscript submission, no authorship changes (including the authorship list, author order, and who is designated as the corresponding author) should be made unless there is a substantive reason to do so. The editor and all co-authors must agree on the change(s), and neither the Journal nor the publisher mediates authorship disputes. If individuals cannot agree on the authorship of a submitted manuscript, please contact the editorial office. The dispute must be resolved among the individuals and their institution(s) before the manuscript can be accepted for publication. If an authorship dispute or change arises after a paper is accepted, contact OUP’s Author Support team. COPE provides guidance for authors on resolving authorship disputes.

After submission, changing who is designated as the corresponding author will be permitted only where there is a substantive reason to do so. For the avoidance of doubt, changing the corresponding author in order to access Read and Publish funding is not permissible. For more information on Read and Publish funding, see the Open Access section.

CRediT

The Journal uses the contributor roles taxonomy (CRediT), which allows authors to describe the contributor roles in a standardized, transparent, and accurate way. Authors should choose from the contributor roles outlined on the CRediT website and supply this information upon submission. You may choose multiple contributor roles per author. Any other individuals who do not meet authorship criteria and made less substantive contributions should be listed in your manuscript as non-author contributors with their contributions clearly described. Following manuscript submission, any changes to contributor roles require the approval of the editor.

Human subjects

All studies involving human subjects require prior Institutional Review Board (IRB) approval. This applies to prospective and retrospective studies that involve any direct interaction with patients or collection of private information (including imaging studies or chart reviews). If the IRB at the participating institution does not require approval for the study type submitted, this must be stated in the manuscript with full explanation. Otherwise, manuscripts must include a statement in the Methods section that the research was performed after approval by an institutional review board, local ethics committee, and/or local licensing committee, or that such approval was not required. The name of the authorizing body and any reference/permit numbers (where available) should also be stated there. Please be prepared to provide further information to the editorial office upon request.

If no IRB existed at the time the study was initiated, you should indicate whether the procedures followed were in accordance with the ethical standards of the Helsinki Declaration, which were developed by the World Medical Association.

Human subjects must give written informed consent, or if they are minors or incapacitated, such consent must be obtained from their parents or guardians. Consent forms should cover not only study participation but also the publication of the data collected. Also, any patient or provider information should be anonymized to the extent possible; names and ID numbers should not be used in the text and must be removed from any images (X-rays, photographs, etc.). Please note that blanking out an individual’s eyes in a photograph is not an effective way to conceal their identity. In studies where verbal, rather than written, informed consent was obtained, this must be explained and stated within the manuscript. If informed consent is not required or where a study has been granted an exemption, this must be included in the Methods section along with the name of the authorizing body. Please be prepared to provide written consent forms signed by the participants or other appropriate documentation to the editorial office upon request.

It is the author's responsibility to ensure that patient anonymity is carefully protected. Authors from U.S. institutions must comply with all regulations of the Health Insurance Portability and Accountability Act (HIPAA) of 1996. Consent must be also recorded when photographs of patients are shown or other details are given that could lead to the identification of these individuals.

Clinical trials

The Journal of Breast Imaging follows recommendations from the World Health Organization and the ICMJE pertaining to clinical trial registration and reporting. All manuscripts reporting results from clinical trials must be registered in an approved clinical trial registry, such as ClinicalTrials.gov prior to the enrollment of the first participation, in accordance with the criteria outlined by the ICMJE. When reporting primary or secondary analyses from a clinical trial, follow these criteria:

• Provide the trial registration number at the end of the Abstract.
• When the trial acronym is first used in the manuscript, provide the registration number and a link to the trial registration, which should be cited as a reference.
• If your data have been deposited in a public repository and/or are being used in a secondary analysis, please state at the end of the Abstract the unique, persistent data set identifier, and repository name and number.
• When submitting the manuscript, you must disclose any protocol alterations and all posting of results of the submitted work or closely related work in registries.
• In reporting randomized clinical trials, you must comply with published CONSORT guidelines
• Complete the recommended checklist and be prepared to provide it to the editorial office upon request.
• Present the recommended trial flow diagram as a figure in the manuscript or as supplementary material.
• If your manuscript reports on a randomized Phase II/III trial, you must provide a brief description of the statistical plan of the original study that includes the primary and secondary endpoints, power calculation, and sample size.

Animal subjects

The Journal of Breast Imaging does not publish animal studies.

Plagiarism

Manuscripts submitted to JBI may be screened with iThenticate anti-plagiarism software in an attempt to detect and prevent plagiarism. Any manuscript may be screened, especially if there is reason to suppose part or all of the text has been previously published. Prior to final acceptance, any manuscript that has not already been screened may be put through iThenticate. More information about iThenticate.

Disclosure

Once an article is likely to be accepted, manuscript authors will be required to complete an ICMJE Conflict of Interest form prior to publication. These forms are available via the ICMJE website, or are available on request from the journal editorial office, [email protected].

Any financial interests or connections, direct or indirect, or other situations that might raise the question of bias in the work reported or the conclusions, implications, or opinions stated—including pertinent commercial or other sources of funding for the individual author(s) or for the associated department(s) or organization(s), personal relationships, or direct academic competition—should be disclosed. For further information see the FAQ.

If there are none, please declare no conflicts of interest.

If one or a few authors have a conflict to disclose, further to that statement, there should be an additional statement for those remaining authors who do not have any conflicts of interest.

Members of the editorial staff of the journal should include the following COI disclosure in their article: “[Author initial] holds the position of [Editor-in-Chief/Associate Editor/Board Member/etc.] for the Journal of Breast Imaging  and has been recused from reviewing or making decisions for the manuscript​.”

Privacy policies

OUP's policy on data and privacy.

Data Policy

Third-party permissions

In order to reproduce any third party material, including tables, figures, or images, in an article authors must obtain permission from the copyright holder and be compliant with any requirements the copyright holder may have pertaining to this reuse. When seeking to reproduce any kind of third party material authors should request the following:

• non-exclusive rights to reproduce the material in the specified article and journal;
• print and electronic rights, preferably for use in any form or medium;
• the right to use the material for the life of the work; and
• world-wide English-language rights.

It is particularly important to clear permission for use in both the print and online versions of the journal, and we are not able to accept permissions which carry a time limit because we retain journal articles as part of our online journal archive. Further guidelines on clearing permissions.

Author's Retained Rights and Self-archiving Policy

As an author of an article in JBI, you retain the right to:

• use all or part of the article and abstract for your own personal use, including your own classroom teaching purposes;
• use all or part of the article and abstract in the preparation of derivative works, extension of the article into book-length or in other works, provided that a full acknowledgement is made to the original publication in JBI;
• include the article in full or in part in a thesis or dissertation, provided that this is not published commercially.

For the above uses, there is no need for the author to apply for written permission in advance. Please include a full acknowledgment of the source when reusing the material you authored. The only exception to these uses if for the re-use of material for commercial purposes, e.g., republication or distribution of an article by a for-profit publisher or medical communications company. Permission for this kind of re-use is required and can be obtained through Rightslink. Information on publication rights.

Additionally, JBI authors can self-archive versions of your work on your own webpages, on institutional webpages, and in other repositories. The journal’s self-archiving policy.

Permissions regarding re-use of OUP material

Guidelines on permissions for the reuse of OUP material.

Funding agency policies

See OUP's Funder Policy page for information about compliance with funding agency requirements including PubMed/PMC deposits.

All work must be submitted through the JBI peer-review website hosted by ScholarOne. JBI uses a double-anonymized review process. As such, please ensure that there are no references to personal prior work (e.g. using a statement such as "In our prior study (5), we demonstrated...") and that identities are masked (use XXX for reader identity for example) until paper is accepted.

Availability of Data and Materials

Where ethically feasible, JBI strongly encourages authors to make all data and software code on which the conclusions of the paper rely available to readers. We suggest that data be presented in the main manuscript or additional supporting files, or deposited in a public repository whenever possible. For information on general repositories for all data types, and a list of recommended repositories by subject area, please see Choosing where to archive your data.

Data Citation

JBI supports the Force 11 Data Citation Principles and requires that all publicly available datasets be fully referenced in the reference list with an accession number or unique identifier such as a digital object identifier (DOI). Data citations should include the minimum information recommended by DataCite:

• [dataset]* Authors, Year, Title, Publisher (repository or archive name), Identifier

*The inclusion of the [dataset] tag at the beginning of the citation helps us to correctly identify and tag the citation. This tag will be removed from the citation published in the reference list.

Preprint Policy

Authors retain the right to make an Author’s Original Version (preprint) available through various channels, and this does not prevent submission to the journal. For further information see our Online Licensing, Copyright and Permissions policies. If accepted, the authors are required to update the status of any preprint, including your published paper’s DOI, as described on our Author Self-Archiving policy page.